Go Pro
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free MODD Stock Alerts

Modular Medical (MODD) Financials

Modular Medical logo
$3.00 -0.24 (-7.25%)
As of 02:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Modular Medical

Annual Income Statements for Modular Medical

This table shows Modular Medical's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Consolidated Net Income / (Loss)		 -0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Net Income / (Loss) Continuing Operations		 -0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Total Pre-Tax Income 		-0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Total Operating Income		 -0.01 -0.09 -0.67 -2.58 -5.35 -7.34 -15 -14 -18 -19 -28
Total Gross Profit		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 0.01 0.09 0.67 2.58 5.35 7.34 15 14 18 19 28
Selling, General & Admin Expense		 0.01 0.09 0.33 0.69 2.31 3.25 7.20 4.82 4.65 4.35 7.59
Research & Development Expense		 - - 0.33 1.88 3.03 4.08 7.73 9.06 13 15 20
Total Other Income / (Expense), net		 -0.02 -0.02 0.01 0.04 0.03 -0.04 -3.70 0.00 0.06 0.23 -0.84
Other Income / (Expense), net		 - - - - - - 0.37 - 0.06 0.23 -0.84
Income Tax Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share		 ($0.02) ($0.06) ($0.05) ($0.15) ($0.30) - ($2.74) ($1.15) ($0.78) ($15.26) ($12.36)
Weighted Average Basic Shares Outstanding		 1.25M 15.98M 13.34M 16.59M 17.86M -1.20 6.81M 12.10M 22.38M 1.23M 2.29M
Diluted Earnings per Share		 ($0.02) ($0.06) ($0.05) ($0.15) ($0.30) - - - ($0.78) ($15.26) ($12.36)
Weighted Average Diluted Shares Outstanding		 1.25M 15.98M 13.34M 16.59M 17.86M -1.20 -2.74 21.09M 22.38M 1.23M 2.29M
Weighted Average Basic & Diluted Shares Outstanding		 1.25M 1.65M 15.98M 16.59M 17.86M 6.21M -2.74 21.09M 32.54M - 5.41B

Quarterly Income Statements for Modular Medical

This table shows Modular Medical's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -4.18 -5.27 -4.28 -4.14 -4.96 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Consolidated Net Income / (Loss)		 -4.18 -5.27 -4.28 -4.14 -4.96 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Net Income / (Loss) Continuing Operations		 -4.18 -5.27 -4.27 -4.14 -4.96 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Total Pre-Tax Income 		-4.18 -5.27 -4.27 -4.14 -4.95 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Total Operating Income		 -4.19 -5.27 -4.32 -4.22 -5.00 -4.85 -4.98 -6.80 -7.83 -7.24 -5.68
Total Operating Expenses		 4.19 5.27 4.32 4.22 5.00 4.85 4.98 6.80 7.83 7.24 5.68
Selling, General & Admin Expense		 1.03 1.43 1.20 1.02 1.29 1.00 1.04 1.67 2.24 1.84 1.84
Research & Development Expense		 3.16 3.84 3.12 3.21 3.70 3.85 3.94 5.13 5.59 5.41 3.84
Total Other Income / (Expense), net		 0.01 0.00 0.05 0.08 0.04 0.05 0.05 0.10 0.04 -0.12 -0.86
Other Income / (Expense), net		 0.01 0.00 - 0.08 0.04 0.05 0.05 0.10 0.04 -0.12 -0.86
Basic Earnings per Share		 ($0.19) ($0.23) ($0.14) ($0.12) ($0.14) ($0.13) ($4.00) ($0.12) ($0.14) ($0.11) ($2.80)
Weighted Average Basic Shares Outstanding		 22.45M 22.54M 22.38M 33.88M 34.34M 37.81M 1.23M 54.29M 55.58M 65.93M 2.29M
Diluted Earnings per Share		 ($0.19) ($0.23) - ($0.12) ($0.14) ($0.13) ($4.00) ($0.12) ($0.14) ($0.11) ($2.80)
Weighted Average Diluted Shares Outstanding		 22.45M 22.54M 22.38M 33.88M 34.34M 37.81M 1.23M 54.29M 55.58M 65.93M 2.29M
Basic & Diluted Earnings per Share		 - - - - - - ($4.00) - - - ($2.80)
Weighted Average Basic & Diluted Shares Outstanding		 21.12M 21.90M 32.54M 32.56M - - 0.00 - - - 5.41B

Annual Cash Flow Statements for Modular Medical

This table details how cash moves in and out of Modular Medical's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Net Change in Cash & Equivalents		 0.00 1.37 3.90 2.26 -3.43 -1.65 7.61 -5.28 5.43 3.86 -6.15
Net Cash From Operating Activities		 -0.01 -0.09 -0.79 -1.81 -4.09 -5.91 -10 -11 -14 -16 -24
Net Cash From Continuing Operating Activities		 -0.01 -0.09 -0.79 -1.81 -4.09 -5.96 -10 -11 -14 -16 -24
Net Income / (Loss) Continuing Operations		 -0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Consolidated Net Income / (Loss)		 -0.03 -0.11 -0.66 -2.54 -5.32 -7.38 -19 -14 -17 -19 -28
Depreciation Expense		 - - 0.00 0.01 0.04 0.11 0.12 0.15 0.43 1.06 1.67
Non-Cash Adjustments To Reconcile Net Income		 - - 0.00 0.55 0.71 1.33 6.05 2.93 3.08 2.80 2.60
Changes in Operating Assets and Liabilities, net		 0.02 0.01 -0.13 0.16 0.48 -0.11 0.30 -0.21 0.01 -0.76 0.22
Net Cash From Investing Activities		 0.00 0.00 -0.02 -0.08 -0.26 -0.11 -0.05 -1.64 -1.70 -2.49 -3.93
Net Cash From Continuing Investing Activities		 0.00 0.00 -0.02 -0.08 -0.26 -0.11 -0.05 -1.64 -1.70 -2.49 -3.93
Purchase of Property, Plant & Equipment		 - - -0.02 -0.08 -0.26 -0.11 -0.05 -1.64 -1.70 -2.49 -3.93
Net Cash From Financing Activities		 0.01 1.47 4.71 4.14 0.92 4.36 18 7.37 21 22 22
Net Cash From Continuing Financing Activities		 0.01 1.47 4.71 4.14 0.92 4.36 18 7.37 21 22 22
Repayment of Debt		 - -0.13 -0.02 - - - 0.00 - - 0.00 -0.25
Issuance of Debt		 0.01 - - 0.00 0.00 2.58 4.14 - - 0.00 0.25
Issuance of Common Equity		 0.00 1.61 4.73 4.14 0.92 1.79 14 7.37 20 21 22
Other Financing Activities, net		 - - - - - - - 0.00 0.74 1.25 0.01
Cash Interest Paid		 0.00 0.02 0.00 - - 0.00 0.26 - - 0.00 0.03
Cash Income Taxes Paid		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for Modular Medical

This table details how cash moves in and out of Modular Medical's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -3.62 -4.28 7.19 -4.18 -1.16 3.09 6.11 -5.57 -2.21 -2.38 4.01
Net Cash From Operating Activities		 -3.28 -3.97 -3.50 -3.55 -3.77 -4.10 -4.31 -5.37 -5.41 -7.16 -5.82
Net Cash From Continuing Operating Activities		 -3.28 -3.97 -3.50 -3.55 -3.77 -4.10 -4.31 -5.37 -5.41 -7.16 -5.81
Net Income / (Loss) Continuing Operations		 -4.18 -5.27 -4.28 -4.14 -4.96 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Consolidated Net Income / (Loss)		 -4.18 -5.27 -4.28 -4.14 -4.96 -4.80 -4.93 -6.70 -7.79 -7.36 -6.39
Depreciation Expense		 0.10 0.13 0.14 0.20 0.26 0.28 0.33 0.41 0.39 0.43 0.44
Non-Cash Adjustments To Reconcile Net Income		 0.76 1.11 0.75 0.63 1.17 0.53 0.47 0.82 0.91 0.77 0.10
Changes in Operating Assets and Liabilities, net		 0.05 0.07 -0.11 -0.24 -0.24 -0.11 -0.18 0.10 1.07 -0.99 0.04
Net Cash From Investing Activities		 -0.35 -0.50 -0.48 -0.84 -0.16 -0.54 -0.95 -0.93 -0.77 -1.22 -1.01
Net Cash From Continuing Investing Activities		 -0.35 -0.50 -0.48 -0.84 -0.16 -0.54 -0.95 -0.93 -0.77 -1.22 -1.01
Purchase of Property, Plant & Equipment		 -0.35 -0.50 -0.48 -0.84 -0.16 -0.54 -0.95 -0.93 -0.77 -1.22 -1.01
Net Cash From Financing Activities		 - 0.18 11 0.21 2.77 7.73 11 0.73 3.98 6.00 11
Net Cash From Continuing Financing Activities		 - 0.18 11 0.21 2.77 7.73 11 0.73 3.98 6.00 11
Issuance of Common Equity		 - 0.18 10 0.00 1.92 7.54 11 0.73 3.98 6.00 11

Annual Balance Sheets for Modular Medical

This table presents Modular Medical's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
Total Assets		 0.00 1.37 4.33 6.65 3.86 2.25 9.85 7.25 14 19 15
Total Current Assets		 0.00 1.37 4.31 6.57 3.19 1.65 9.39 4.05 9.70 14 7.54
Cash & Equivalents		 0.00 1.37 4.30 6.55 3.12 1.47 9.08 3.80 9.23 13 6.94
Prepaid Expenses		 - - - 0.02 0.06 0.18 0.31 0.15 0.47 0.42 0.60
Plant, Property, & Equipment, net		 0.00 0.00 0.01 0.08 0.30 0.30 0.24 1.72 2.98 4.45 6.87
Total Noncurrent Assets		 0.00 0.00 0.01 0.01 0.37 0.30 0.22 1.48 1.14 0.77 0.42
Other Noncurrent Operating Assets		 - - 0.01 0.01 0.37 0.30 0.22 1.48 1.14 0.77 0.42
Total Liabilities & Shareholders' Equity		 0.00 1.37 4.33 6.65 3.86 2.25 9.85 7.25 14 19 15
Total Liabilities		 0.19 0.07 0.02 0.18 0.98 3.52 1.01 2.17 2.27 1.66 1.87
Total Current Liabilities		 0.19 0.07 0.02 0.18 0.66 3.30 0.97 0.98 1.46 1.27 1.87
Accounts Payable		 0.13 0.00 0.02 0.14 0.37 0.17 0.30 0.29 0.80 0.34 0.99
Accrued Expenses		 0.00 0.07 - 0.04 0.20 0.50 0.52 0.34 0.28 0.50 0.49
Other Current Liabilities		 - - - 0.00 0.09 0.13 0.14 0.36 0.37 0.42 0.39
Total Noncurrent Liabilities		 0.00 0.00 0.00 0.00 0.32 0.23 0.04 1.19 0.82 0.39 0.00
Other Noncurrent Operating Liabilities		 - - - 0.00 0.32 0.23 0.04 1.19 0.82 0.39 0.00
Commitments & Contingencies		 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -0.19 1.30 4.32 6.47 2.88 -1.28 8.84 5.08 12 17 13
Total Preferred & Common Equity		 -0.19 1.30 4.32 6.47 2.88 -1.28 8.84 5.08 12 17 13
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -0.19 1.30 4.32 6.47 2.88 -1.28 8.84 5.08 12 17 13
Common Stock		 0.08 0.31 5.03 9.72 11 15 43 54 77 102 126
Retained Earnings		 -0.28 -0.38 -0.71 -3.25 -8.57 -16 -35 -48 -66 -85 -113

Quarterly Balance Sheets for Modular Medical

This table presents Modular Medical's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 6/30/2024 9/30/2024 12/31/2024 6/30/2025 9/30/2025 12/31/2025
Total Assets		 10 6.20 10 8.77 12 14 13 10
Total Current Assets		 6.46 2.34 5.41 4.18 7.33 8.29 5.95 3.47
Cash & Equivalents		 6.33 2.05 5.05 3.89 6.99 7.52 5.32 2.94
Prepaid Expenses		 0.13 0.30 0.36 0.28 0.35 0.77 0.63 0.53
Plant, Property, & Equipment, net		 2.29 2.63 3.62 3.64 3.96 5.21 6.46 6.33
Total Noncurrent Assets		 1.31 1.22 1.05 0.95 0.86 0.67 0.57 0.47
Other Noncurrent Operating Assets		 1.31 1.22 1.05 0.95 0.86 0.67 0.57 0.47
Total Liabilities & Shareholders' Equity		 10 6.20 10 8.77 12 14 13 10
Total Liabilities		 2.12 2.35 2.06 1.86 1.89 2.33 4.21 4.38
Total Current Liabilities		 1.11 1.44 1.34 1.24 1.38 2.05 4.04 2.18
Accounts Payable		 0.55 0.70 0.46 0.50 0.52 1.07 2.88 1.01
Accrued Expenses		 0.22 0.37 0.50 0.35 0.45 0.55 0.72 0.71
Other Current Liabilities		 0.35 0.36 0.39 0.40 0.41 0.44 0.45 0.46
Total Noncurrent Liabilities		 1.01 0.92 0.71 0.61 0.50 0.28 0.16 2.20
Other Noncurrent Operating Liabilities		 1.01 0.92 0.71 0.61 0.50 0.28 0.16 2.20
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 7.94 3.85 8.02 6.92 10 12 8.77 5.88
Total Preferred & Common Equity		 7.94 3.85 8.02 6.92 10 12 8.77 5.88
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 7.94 3.85 8.02 6.92 10 12 8.77 5.88
Common Stock		 64 65 78 82 90 103 108 112
Retained Earnings		 -56 -62 -70 -75 -80 -91 -99 -107
Other Equity Adjustments		 - - - - - - 0.44 0.01

Annual Metrics And Ratios for Modular Medical

This table displays calculated financial ratios and metrics derived from Modular Medical's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 3/31/2018 3/31/2019 3/31/2020 3/31/2021 3/31/2022 3/31/2023 3/31/2024 3/31/2025 3/31/2026
DEI Shares Outstanding		 1,249,816.00 3,500,000.00 15,983,273.00 17,799,705.00 17,870,261.00 18,832,648.00 6,390,372.00 10,932,098.00 21,899,058.00 21,899,058.00 21,899,058.00
DEI Adjusted Shares Outstanding		 1,249,816.00 3,500,000.00 15,983,273.00 17,799,705.00 17,870,261.00 18,832,648.00 6,390,372.00 10,932,098.00 21,899,058.00 729,969.00 729,969.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.02 -0.03 -0.04 -0.14 -0.30 -0.39 -2.92 -1.27 -0.80 -25.79 -38.69
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 18.32% -591.72% -629.59% -285.79% -107.29% -34.45% -76.50% -8.88% -24.16% -4.21% -50.48%
EBIT Growth		 18.32% -591.72% -631.64% -286.89% -107.50% -37.19% -98.42% 4.67% -25.87% -7.75% -50.86%
NOPAT Growth		 18.32% -591.72% -631.64% -286.89% -107.50% -37.19% -103.45% 7.02% -26.31% -8.67% -44.69%
Net Income Growth		 -0.29% -242.81% -518.67% -285.21% -109.52% -38.66% -152.55% 25.51% -25.87% -7.75% -50.03%
EPS Growth		 0.00% -200.00% 18.33% -206.12% -100.00% 0.00% 0.00% 0.00% 0.00% -7.75% -50.03%
Operating Cash Flow Growth		 0.00% -789.15% -734.44% -128.53% -126.49% -44.30% -73.64% -7.32% -26.71% -12.67% -51.10%
Free Cash Flow Firm Growth		 -18.32% -3,149.15% -367.61% -202.30% -110.31% -43.54% -103.39% -7.47% -18.39% -12.91% -42.06%
Invested Capital Growth		 -11.16% 43.23% 129.97% -457.37% -205.74% 0.96% 0.75% 633.01% 80.34% 72.90% 51.11%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 12.40% -694.03% 0.00% 0.00% 0.00% 3.14% -14.82% 3.36% -3.66% -1.43% -5.96%
EBIT Q/Q Growth		 12.40% -694.03% 0.00% 0.00% 0.00% 2.44% -15.24% 3.18% -4.09% -2.35% -6.04%
NOPAT Q/Q Growth		 12.40% -694.03% 0.00% 0.00% 0.00% 2.44% -18.17% 3.18% -4.45% -3.58% -2.63%
Net Income Q/Q Growth		 3.62% -386.95% 0.00% 0.00% 0.00% 1.93% -17.70% 6.74% -4.23% -3.55% -5.46%
EPS Q/Q Growth		 0.00% -1,900.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5.46%
Operating Cash Flow Q/Q Growth		 0.00% -789.15% -45.21% 0.00% 0.00% -0.34% -21.17% 2.68% -5.09% -5.41% -6.76%
Free Cash Flow Firm Q/Q Growth		 -12.40% -11.50% 0.00% 0.00% 0.00% -2.03% -37.40% 5.07% -0.63% -4.62% -15.49%
Invested Capital Q/Q Growth		 -1.36% -153.34% 0.00% 0.00% 0.00% -5.63% 83.65% 283.96% 28.09% 21.55% 104.38%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.00% 100.00% 100.24% 100.06% 100.03% 100.02% 100.01% 100.01% 100.01% 100.01% 100.01%
Interest Burden Percent		 236.15% 117.03% 98.72% 98.47% 99.46% 100.54% 127.98% 99.99% 100.00% 100.00% 99.45%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 17.44% -19.30% -23.47% -47.06% -113.79% -920.36% -492.82% -199.51% -210.34% -131.58% -188.05%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% -2,524.28% 0.00% 0.00% 0.00% 0.00% -879.50% -742.81% -477.73% -426.58%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 17.44% -19.30% -23.47% -47.06% -113.79% -920.36% -492.82% -199.51% -210.34% -131.58% -188.05%
Return on Equity Simple (ROE_SIMPLE)		 16.04% -8.21% -15.26% -39.23% -184.85% 578.60% -210.85% -273.42% -151.45% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.01 -0.06 -0.47 -1.80 -3.74 -5.14 -10 -9.71 -12 -13 -19
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 40.72% -6.54% -6.81% -13.56% -32.60% -214.74% -203.52% -64.69% -79.81% -49.18% -89.33%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -106.37% -78.08% -148.87%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -0.01 -0.09 -0.67 -2.58 -5.35 -7.34 -15 -14 -17 -19 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.01 -0.09 -0.66 -2.56 -5.31 -7.14 -13 -14 -17 -18 -27
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 3.32 0.83 0.69 1.49 0.00 0.00 6.02 3.59 2.36 0.93
Price to Tangible Book Value (P/TBV)		 0.00 3.32 0.83 0.69 1.49 0.00 0.00 6.02 3.59 2.36 0.93
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20.97 13.97 6.84 0.85
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 85.45 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 -1.96 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.30 -1.19 -1.01 -1.01 -1.03 -1.30 -1.06 -0.93 -0.78 -0.78 -0.67
Leverage Ratio		 -0.01 1.24 1.02 1.02 1.12 3.81 1.60 1.23 1.27 1.14 1.12
Compound Leverage Factor		 -0.02 1.45 1.00 1.00 1.12 3.83 2.05 1.23 1.27 1.14 1.11
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 203.92% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 203.92% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% -103.92% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.35 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 -0.14 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.49 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 -0.20 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.00 35.32 140.10 14.23 -4.27 0.00 0.00 -6.72 0.79 5.73 -12.66
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 18.44 278.81 36.71 4.82 0.50 9.68 4.13 6.66 10.69 4.03
Quick Ratio		 0.00 18.44 277.72 36.63 4.72 0.45 9.36 3.88 6.35 10.35 3.71
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -0.12 -0.56 -1.70 -3.58 -5.14 -10 -11 -13 -15 -21
Operating Cash Flow to CapEx		 0.00% 0.00% -5,232.69% -2,344.19% -1,570.17% -5,387.72% -18,734.07% -672.22% -820.71% -630.57% -604.09%
Free Cash Flow to Firm to Interest Expense		 0.22 -7.76 0.00 0.00 0.00 -129.55 -2.57 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -0.60 -6.11 0.00 0.00 0.00 -148.98 -2.52 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -0.60 -6.11 0.00 0.00 0.00 -151.74 -2.53 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.13 -0.07 0.02 -0.08 -0.24 -0.24 -0.24 1.28 2.30 3.98 6.02
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 -0.01 0.06 0.10 -0.10 -0.16 0.00 0.00 1.52 1.03 1.68 2.04
Enterprise Value (EV)		 0.34 2.94 -0.70 -2.07 1.17 0.00 0.00 27 32 27 5.12
Market Capitalization		 0.34 4.32 3.60 4.48 4.29 -0.00 -0.00 31 41 40 12
Book Value per Share		 ($0.16) $0.37 $0.27 $0.36 $0.16 ($0.07) $1.38 $0.46 $0.53 $13.85 $5.67
Tangible Book Value per Share		 ($0.16) $0.37 $0.27 $0.36 $0.16 ($0.07) $1.38 $0.46 $0.53 $13.85 $5.67
Total Capital		 -0.19 1.30 4.32 6.47 2.88 1.23 8.84 5.08 12 17 13
Total Debt		 0.00 0.00 0.00 0.00 0.00 2.50 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 0.00 -1.37 -4.30 -6.55 -3.12 1.03 -9.08 -3.80 -9.23 -13 -6.94
Capital Expenditures (CapEx)		 0.00 0.00 0.02 0.08 0.26 0.11 0.05 1.64 1.70 2.49 3.93
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.19 -0.07 0.00 -0.16 -0.60 -0.61 -0.66 -0.73 -0.99 -0.84 -1.27
Debt-free Net Working Capital (DFNWC)		 -0.19 1.30 4.30 6.39 2.52 0.85 8.42 3.07 8.24 12 5.67
Net Working Capital (NWC)		 -0.19 1.30 4.30 6.39 2.52 -1.65 8.42 3.07 8.24 12 5.67
Net Nonoperating Expense (NNE)		 0.02 0.04 0.19 0.74 1.58 2.24 8.18 4.16 5.20 5.49 8.95
Net Nonoperating Obligations (NNO)		 0.06 -1.37 -4.30 -6.55 -3.12 1.03 -9.08 -3.80 -9.23 -13 -6.94
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.01 0.04 0.19 1.95 0.15 0.43 1.06 1.67
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.02) ($0.06) ($0.05) ($0.15) ($0.30) ($0.40) $0.00 ($1.28) ($0.78) ($15.30) ($12.36)
Adjusted Weighted Average Basic Shares Outstanding		 1.25M 15.98M 13.34M 16.59M 18.45M 18.97M 10.91M 10.88M 22.38M 1.23M 2.29M
Adjusted Diluted Earnings per Share		 ($0.02) ($0.06) ($0.05) ($0.15) ($0.30) ($0.40) $0.00 $0.00 $0.00 ($15.30) ($12.36)
Adjusted Weighted Average Diluted Shares Outstanding		 1.25M 15.98M 13.34M 16.59M 18.45M 18.97M 10.91M 21.09M 32.54M 1.23M 2.29M
Adjusted Basic & Diluted Earnings per Share		 ($0.02) ($0.06) ($0.05) ($0.15) ($0.30) ($0.40) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1.25M 1.65M 15.98M 17.87M 17.86M 18.63M 6.81M 21.09M 32.54M 0.00 5.41B
Normalized Net Operating Profit after Tax (NOPAT)		 -0.01 -0.06 -0.47 -1.80 -3.74 -5.14 -10 -9.71 -12 -13 -19
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -0.73 -5.87 0.00 0.00 0.00 -184.99 -3.57 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -0.51 -4.11 0.00 0.00 0.00 -129.49 -2.56 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -0.73 -5.87 0.00 0.00 0.00 -187.75 -3.59 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -0.51 -4.11 0.00 0.00 0.00 -132.26 -2.58 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -13.23% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Modular Medical

This table displays calculated financial ratios and metrics derived from Modular Medical's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 21,095,198.00 21,123,726.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00
DEI Adjusted Shares Outstanding		 21,095,198.00 21,123,726.00 21,899,058.00 21,899,058.00 21,899,058.00 21,899,058.00 729,969.00 21,899,058.00 21,899,058.00 21,899,058.00 729,969.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.20 -0.25 -0.20 -0.19 -0.23 -0.22 -6.75 -0.31 -0.36 -0.34 -8.75
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth		 -19.54% -54.56% -18.87% -6.72% -14.88% 11.99% -10.18% -59.65% -57.58% -53.22% -32.67%
EBIT Growth		 -21.22% -56.91% -20.91% -10.29% -18.49% 8.83% -14.08% -62.00% -57.21% -53.21% -32.84%
NOPAT Growth		 -21.48% -56.91% -20.91% -12.50% -19.24% 7.88% -15.26% -61.23% -56.71% -49.24% -14.16%
Net Income Growth		 -21.25% -56.91% -19.85% -10.70% -18.48% 8.83% -15.09% -62.00% -57.18% -53.21% -29.69%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 26.32% 43.48% 0.00% 0.00% 0.00% 15.38% -29.69%
Operating Cash Flow Growth		 -14.94% -49.17% -23.91% -10.63% -14.92% -3.30% -23.04% -51.41% -43.68% -74.68% -34.92%
Free Cash Flow Firm Growth		 -38.07% -24.24% -0.80% 3.63% -5.89% 5.39% -27.52% -41.86% -20.32% 2.81% -16.45%
Invested Capital Growth		 1,739.60% 440.61% 80.34% 84.79% 88.00% 82.20% 72.90% 45.78% 14.22% -10.13% 51.11%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 -10.64% -25.77% 18.74% 5.63% -19.11% 3.64% -1.72% -36.75% -17.56% 6.31% 11.92%
EBIT Q/Q Growth		 -11.46% -26.02% 18.03% 4.21% -19.75% 3.03% -2.56% -36.03% -16.20% 5.50% 11.07%
NOPAT Q/Q Growth		 -11.70% -25.75% 18.03% 2.29% -18.39% 2.84% -2.55% -36.68% -15.06% 7.47% 21.55%
Net Income Q/Q Growth		 -11.93% -25.96% 18.75% 3.36% -19.80% 3.07% -2.56% -36.03% -16.23% 5.52% 13.18%
EPS Q/Q Growth		 0.00% -21.05% 0.00% 0.00% -16.67% 7.14% -2.56% 0.00% -16.67% 21.43% 13.18%
Operating Cash Flow Q/Q Growth		 -2.18% -20.99% 11.65% -1.28% -6.14% -8.76% -5.22% -24.64% -0.73% -32.23% 18.73%
Free Cash Flow Firm Q/Q Growth		 -3.64% -11.09% 21.43% -6.54% -13.87% 0.74% -5.90% -18.52% 3.42% 19.82% -26.89%
Invested Capital Q/Q Growth		 0.25% 11.82% 28.09% 28.70% 1.99% 8.37% 21.55% 8.51% -20.09% -14.74% 104.38%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent		 100.05% 100.00% 100.33% 100.00% 100.04% 100.00% 100.00% 100.00% 100.03% 100.00% 100.00%
Interest Burden Percent		 100.00% 100.00% 98.80% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 97.63%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -158.99% -282.44% -210.34% -182.61% -251.02% -257.72% -131.58% -215.41% -308.87% -331.77% -188.05%
Cash Return on Invested Capital (CROIC)		 -753.47% -1,240.30% -742.81% -611.15% -629.57% -565.64% -477.73% -452.97% -542.17% -593.78% -426.58%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)		 -158.99% -282.44% -210.34% -182.61% -251.02% -257.72% -131.58% -215.41% -308.87% -331.77% -188.05%
Return on Equity Simple (ROE_SIMPLE)		 -187.07% -435.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.93 -3.69 -3.02 -2.95 -3.50 -3.40 -3.48 -4.76 -5.48 -5.07 -3.98
NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -14.56% -32.46% -19.30% -15.77% -28.54% -31.13% -12.92% -30.84% -50.16% -46.14% -24.07%
Return On Investment Capital (ROIC_SIMPLE)		 - -95.92% -26.21% -36.85% -50.57% -33.11% -20.41% -40.22% -62.50% -86.22% -30.70%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)		 -4.18 -5.27 -4.32 -4.14 -4.95 -4.80 -4.93 -6.70 -7.79 -7.36 -6.55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -4.09 -5.14 -4.18 -3.94 -4.69 -4.52 -4.60 -6.29 -7.40 -6.93 -6.10
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.28 10.67 3.59 6.68 11.17 5.05 2.36 3.42 4.44 4.08 0.93
Price to Tangible Book Value (P/TBV)		 3.28 10.67 3.59 6.68 11.17 5.05 2.36 3.42 4.44 4.08 0.93
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 12.26 21.68 13.97 16.36 24.27 13.68 6.84 7.62 9.72 7.16 0.85
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.92 -0.82 -0.78 -0.77 -0.69 -0.64 -0.78 -0.63 -0.59 -0.61 -0.67
Leverage Ratio		 1.15 1.26 1.27 1.21 1.27 1.30 1.14 1.22 1.39 1.39 1.12
Compound Leverage Factor		 1.15 1.26 1.25 1.21 1.27 1.30 1.14 1.22 1.39 1.39 1.09
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -1.21 -6.10 3.93 5.01 11.55 6.55 8.17 0.36 -6.96 -13.48 -7.80
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.81 1.63 6.66 4.03 3.36 5.30 10.69 4.04 1.47 1.59 4.03
Quick Ratio		 5.69 1.42 6.35 3.76 3.13 5.05 10.35 3.67 1.31 1.35 3.71
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -4.64 -5.15 -4.05 -4.31 -4.91 -4.88 -5.16 -6.12 -5.91 -4.74 -6.01
Operating Cash Flow to CapEx		 -949.86% -794.59% -725.26% -421.38% -2,339.13% -755.72% -454.64% -575.16% -701.82% -585.52% -578.61%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1.61 1.80 2.30 2.96 3.02 3.28 3.98 4.32 3.45 2.94 6.02
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital		 1.71 1.47 1.03 1.36 1.42 1.48 1.68 1.36 0.43 -0.33 2.04
Enterprise Value (EV)		 20 39 32 48 73 45 27 33 34 21 5.12
Market Capitalization		 26 41 41 54 77 52 40 40 39 24 12
Book Value per Share		 $0.38 $0.18 $0.53 $0.24 $0.20 $0.27 $13.85 $0.22 $0.16 $0.09 $5.67
Tangible Book Value per Share		 $0.38 $0.18 $0.53 $0.24 $0.20 $0.27 $13.85 $0.22 $0.16 $0.09 $5.67
Total Capital		 7.94 3.85 12 8.02 6.92 10 17 12 8.77 5.88 13
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -6.33 -2.05 -9.23 -5.05 -3.89 -6.99 -13 -7.52 -5.32 -2.94 -6.94
Capital Expenditures (CapEx)		 0.35 0.50 0.48 0.84 0.16 0.54 0.95 0.93 0.77 1.22 1.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.98 -1.14 -0.99 -0.99 -0.96 -1.04 -0.84 -1.28 -3.41 -1.65 -1.27
Debt-free Net Working Capital (DFNWC)		 5.35 0.90 8.24 4.07 2.93 5.95 12 6.24 1.90 1.29 5.67
Net Working Capital (NWC)		 5.35 0.90 8.24 4.07 2.93 5.95 12 6.24 1.90 1.29 5.67
Net Nonoperating Expense (NNE)		 1.25 1.58 1.26 1.18 1.46 1.41 1.44 1.94 2.31 2.29 2.41
Net Nonoperating Obligations (NNO)		 -6.33 -2.05 -9.23 -5.05 -3.89 -6.99 -13 -7.52 -5.32 -2.94 -6.94
Total Depreciation and Amortization (D&A)		 0.10 0.13 0.14 0.20 0.26 0.28 0.33 0.41 0.39 0.43 0.44
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.19) ($0.23) ($0.14) ($0.12) ($0.14) ($0.13) ($120.00) ($0.12) ($0.14) ($0.11) ($84.00)
Adjusted Weighted Average Basic Shares Outstanding		 22.45M 22.54M 22.38M 33.88M 34.34M 37.81M 41.10K 54.29M 55.58M 65.93M 76.17K
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 ($0.14) ($0.13) ($120.00) ($0.12) ($0.14) ($0.11) ($84.00)
Adjusted Weighted Average Diluted Shares Outstanding		 21.12M 21.90M 22.38M 32.56M 34.34M 37.81M 41.10K 54.29M 55.58M 65.93M 76.17K
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 ($120.00) $0.00 $0.00 $0.00 ($84.00)
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 21.12M 21.90M 32.54M 32.56M 0.00 0.00 0.00 0.00 0.00 0.00 180.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.93 -3.69 -3.02 -2.95 -3.50 -3.40 -3.48 -4.76 -5.48 -5.07 -3.98
Normalized NOPAT Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Modular Medical Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Modular Medical's fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Modular Medical's net income appears to be on an upward trend, with a most recent value of -$28.24 million in 2026, rising from -$31.08 thousand in 2016. The previous period was -$18.82 million in 2025. Check out Modular Medical's forecast to explore projected trends and price targets.

Modular Medical's total operating income in 2026 was -$27.56 million, based on the following breakdown:
  • Total Gross Profit: $0.00
  • Total Operating Expenses: $27.56 million

Over the last 10 years, Modular Medical's total revenue changed from $0.00 in 2016 to $0.00 in 2026, a change of 0.0%.

Modular Medical's total liabilities were at $1.87 million at the end of 2026, a 13.0% increase from 2025, and a 866.6% increase since 2016.

In the past 10 years, Modular Medical's cash and equivalents has ranged from $0.00 in 2016 to $13.10 million in 2025, and is currently $6.94 million as of their latest financial filing in 2026.

Over the last 10 years, Modular Medical's book value per share changed from -0.16 in 2016 to 5.67 in 2026, a change of -3,758.9%.


Related Companies

Financial statements for NASDAQ:MODD last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
DOJ Admits It In Court—Your Cash Can Be Seized Without Warning
The Department of Justice recently argued in court that cash may not be legally your property - raising concer...
Priority Gold | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel